Seres Therapeutics, Inc.
Hedge Funds Holdings
Last updated:
Seres Therapeutics, Inc.‘s stocks are currently a part of 82 hedge funds’ portfolios, which represents 44.78% of the total amount of its stocks outstanding. This makes up a total of 48.40M shares of Seres Therapeutics, Inc.. Compared to the previous quarter, the number fell by -53.94% or -56.67M shares fewer. As for the holding position changes, 30.49% (25) of current hedge fund investors increased the number of shares held, 30.49% (25) of current holders sold a part of the shares held, and 17.07% (14) closed the holdings completely. 16 hedge funds are new holders of Seres Therapeutics, Inc. stock in Q1 2023, it is 19.51% of total holders.
Hedge funds holding Seres Therapeutics (Q2 2018 – Q1 2023)
| Q2 2018 | 76 |
|---|---|
| Q3 2018 | 70 |
| Q4 2018 | 67 |
| Q1 2019 | 80 |
| Q2 2019 | 87 |
| Q3 2019 | 74 |
| Q4 2019 | 76 |
| Q1 2020 | 75 |
| Q2 2020 | 91 |
| Q3 2020 | 112 |
| Q4 2020 | 149 |
| Q1 2021 | 150 |
| Q2 2021 | 143 |
| Q3 2021 | 129 |
| Q4 2021 | 145 |
| Q1 2022 | 127 |
| Q2 2022 | 120 |
| Q3 2022 | 117 |
| Q4 2022 | 123 |
| Q1 2023 | 82 |
Hedge funds changes in Seres Therapeutics positions (Q2 2018 – Q1 2023)
| Q2 2018 | 10 | 22 | 22 | 13 | 9 |
|---|---|---|---|---|---|
| Q3 2018 | 4 | 27 | 16 | 10 | 13 |
| Q4 2018 | 4 | 21 | 27 | 7 | 8 |
| Q1 2019 | 16 | 30 | 15 | 3 | 16 |
| Q2 2019 | 24 | 33 | 14 | 14 | 2 |
| Q3 2019 | 9 | 34 | 17 | 22 | -8 |
| Q4 2019 | 11 | 37 | 15 | 9 | 4 |
| Q1 2020 | 10 | 27 | 24 | 8 | 6 |
| Q2 2020 | 22 | 39 | 16 | 5 | 9 |
| Q3 2020 | 38 | 40 | 30 | 17 | -13 |
| Q4 2020 | 55 | 47 | 36 | 18 | -7 |
| Q1 2021 | 25 | 61 | 45 | 22 | -3 |
| Q2 2021 | 20 | 58 | 45 | 27 | -7 |
| Q3 2021 | 28 | 48 | 31 | 42 | -20 |
| Q4 2021 | 38 | 46 | 40 | 21 | 0 |
| Q1 2022 | 6 | 45 | 53 | 23 | 0 |
| Q2 2022 | 18 | 34 | 48 | 23 | -3 |
| Q3 2022 | 20 | 52 | 28 | 25 | -8 |
| Q4 2022 | 22 | 42 | 36 | 16 | 7 |
| Q1 2023 | 16 | 25 | 25 | 14 | 2 |
Hedge funds changes in Seres Therapeutics stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 408,000 | 144,000 |
|---|---|---|
| Q3 2018 | 165,000 | 93,000 |
| Q4 2018 | 4,000 | 124,000 |
| Q1 2019 | 102,000 | 237,000 |
| Q2 2019 | 1,816,000 | 284,000 |
| Q3 2019 | 1,234,000 | 160,000 |
| Q4 2019 | 0 | 144,000 |
| Q1 2020 | 3,000 | 0 |
| Q2 2020 | 3,529,000 | 3,449,000 |
| Q3 2020 | 83,259,000 | 19,325,000 |
| Q4 2020 | 17,674,000 | 6,755,000 |
| Q1 2021 | 35,349,000 | 5,010,000 |
| Q2 2021 | 46,579,000 | 5,936,000 |
| Q3 2021 | 4,700,000 | 2,769,000 |
| Q4 2021 | 3,724,000 | 4,090,000 |
| Q1 2022 | 3,159,000 | 1,989,000 |
| Q2 2022 | 788,000 | 659,000 |
| Q3 2022 | 2,314,000 | 1,309,000 |
| Q4 2022 | 1,870,680 | 1,244,400 |
| Q1 2023 | 836,379,000 | 1,052,991,000 |